Vanda Pharmaceuticals is suing the FDA again, this time alleging the agency is unlawfully delaying a hearing to discuss the rejection of the biotech's stomach disorder drug last year. The FDA has ...

WASHINGTON, April 23, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda") (Nasdaq: VNDA) today announced that FDA bureaucrats have committed to delay Vanda's request for a hearing on the ...

Vanda Pharmaceuticals (NASDAQ:VNDA) is alleging that members of the U.S. FDA "have committed to delay" its request for a hearing to discuss the agency's issuing of a Complete Response Letter in ...

WASHINGTON, May 5, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) informed Vanda that the New Drug ...

Vanda Pharmaceuticals reported its financial results for Q1 2025, revealing a revenue of $50 million, which fell short of the $61.02 million forecast. The company also reported a net loss of $29.5 ...

The Vanda Miss Joaquim was born and bred in Singapore in 1893, in the garden of a woman named Agnes Joaquim, an Armenian horticulturist who lived in Tanjong Pagar.

Despite a 5% revenue increase, Vanda Pharmaceuticals Inc (VNDA) faces challenges with a significant net loss and rising operating expenses. WASHINGTON (AP) — Vanda Pharmaceuticals Inc. VNDA ...

The FDA has declined to approve Vanda Pharma's tradipitant for delayed gastric emptying (gastroparesis), prompting a furious response from the company. In a statement, the company says the FDA's ...

UK group Cycle Pharma has made an unsolicited takeover bid to buy Vanda Pharma of the US, which is already fending off an overture from Future Pak. The $8-per-share offer values Nasdaq-listed ...

The tradipitant saga stretches back to September 2024, when the FDA declined to approve Vanda’s drug in gastroparesis, a stomach condition characterized by delayed gastric emptying. Vanda ...